Literature DB >> 17313515

Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.

Kim Vereecken1, Cynthia W A Naus, Katja Polman, Janet T Scott, Mamadou Diop, Bruno Gryseels, Luc Kestens.   

Abstract

We examined associations between schistosome-specific antibody responses and reinfection in Senegalese individuals recently exposed to Schistosoma mansoni. The effects of treatment, age, intensity of infection and duration of exposure on schistosome-specific antibody responses were also investigated by comparing immune responses in individuals exposed for less than 3 years with responses in people exposed for more than 8 years. All individuals were bled before treatment as well as 6 and 12 weeks after. We used a statistical model that included interaction terms between time, age, infection intensity and duration of exposure. The overall patterns of most specific antibody responses by age were similar to those previously published for S. mansoni, Schistosoma japonicum and Schistosoma haematobium infections in different endemic areas. In general, a boost in specific antibody responses against adult worm antigen (SWA) was observed at 6 weeks after treatment whereas the majority of isotype responses against egg antigen (SEA) were not affected by treatment. Our analysis showed that the effect of treatment on schistosome-specific antibody responses is influenced by age, infection intensity and duration of exposure. We found no evidence that treatment matures the specific antibody response of children recently infected with S. mansoni. Our results indicate that the build-up of potentially protective immunoglobulin E (IgE) responses was associated with duration of exposure, or, in other words, experience of infection. Interestingly, in recently exposed individuals there was a significant association between IgA responses to SWA and resistance to reinfection. Resistance to reinfection and production of IgA-SWA was associated with adulthood independently of exposure patterns, suggesting that susceptibility to S. mansoni and the development of protective immune responses is age-dependent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17313515     DOI: 10.1111/j.1365-3156.2006.01805.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  21 in total

1.  Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.

Authors:  Weidong Zhang; Gul Ahmad; Workineh Torben; Zahid Noor; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald B Podesta; Ronald C Kennedy; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

2.  Factors in the resistance of rats to re-infection and super-infection by Clonorchis sinensis.

Authors:  Hongman Zhang; Byung-Suk Chung; Shunyu Li; Min-Ho Choi; Sung-Tae Hong
Journal:  Parasitol Res       Date:  2008-01-19       Impact factor: 2.289

3.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

4.  Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk.

Authors:  Wesley Rodrigues Pereira; Helmut Kloos; Sara B Crawford; Jorge Gustavo Velásquez-Melendez; Leonardo Ferreira Matoso; Ricardo Toshio Fujiwara; Guilherme Grossi Lopes Cançado; Philip T Loverde; Rodrigo Correa-Oliveira; Andrea Gazzinelli
Journal:  Acta Trop       Date:  2009-09-16       Impact factor: 3.112

5.  Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver.

Authors:  Dianhui Chen; Xueping Luo; Hongyan Xie; Zhiyan Gao; Huilong Fang; Jun Huang
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

6.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

Review 7.  Review: analysis of parasite and other skewed counts.

Authors:  Neal Alexander
Journal:  Trop Med Int Health       Date:  2012-06       Impact factor: 2.622

8.  Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.

Authors:  N Rujeni; N Nausch; N Midzi; T Mduluza; D W Taylor; F Mutapi
Journal:  Parasite Immunol       Date:  2012-06       Impact factor: 2.280

9.  Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray.

Authors:  Angela van Diepen; Cornelis H Smit; Loes van Egmond; Narcis B Kabatereine; Angela Pinot de Moira; David W Dunne; Cornelis H Hokke
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

10.  Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.

Authors:  Lucja A Labuda; Ulysse Ateba-Ngoa; Eliane Ngoune Feugap; Jorn J Heeringa; Luciën E P M van der Vlugt; Regina B A Pires; Ludovic Mewono; Peter G Kremsner; Menno C van Zelm; Ayola A Adegnika; Maria Yazdanbakhsh; Hermelijn H Smits
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.